Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain
NCT ID: NCT00587626
Last Updated: 2010-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
80 participants
INTERVENTIONAL
2007-08-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
H1: InterX therapy will have a moderate effect to reduce pain.
H2: Functional gains will be greater in patients receiving InterX therapy compared to those who received placebo treatment.
H3: Chronic neck and shoulder pain is more prevalent in patients who exhibit radiographic evidence of degenerative spondylosis/arthrosis of the cervical spine.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of the InterX 5000 in the Treatment of Chronic Neck Pain
NCT01382537
Concurrent Treatment for Patients With Cervical Radiculopathy
NCT03636009
Complementary Management of Chronic Neck and/or Low Back Pain With a Pain Relief Kit
NCT03157544
Normalizing Cervical Intersegmental Kinematics With Spinal Manipulative Therapy
NCT06312696
Chiropractic Manual Therapy and Neck Pain
NCT01772966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
InterX treatment plus rehabilitation exercises
InterX 5000 Treatment
Patients will receive will receive InterX treatment 3 times a week for 4 weeks.
2
Inactive InterX treatment plus rehabilitation exercises
Inactive InterX 5000
Patients will receive will receive InterX placebo treatment 3 times a week for 4 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inactive InterX 5000
Patients will receive will receive InterX placebo treatment 3 times a week for 4 weeks.
InterX 5000 Treatment
Patients will receive will receive InterX treatment 3 times a week for 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to sign consent for study participation
* able/willing to comply with treatment schedule
Exclusion Criteria
* spinal fracture
* previous electrical stimulation treatment for this episode
* recent cervical spinal or shoulder surgery or implanted instrumentation/prostheses.
* patients with cardiac pacemaker or spinal cord stimulator, epilepsy, pregnancy, recent (3 months) chemotherapy/radiotherapy, phlebitis, cortisone use (30 days)
18 Years
66 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Memorial Chiropractic College
OTHER
Neuro Resource Group
INDUSTRY
Hamilton Health Sciences Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
McMaster University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Linda J Woodhouse, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
John J Triano, DC, PhD
Role: PRINCIPAL_INVESTIGATOR
Canadian Memorial Chiropractic College
Vickie Galea, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
H Stephen Injeyan, PhD, DC
Role: PRINCIPAL_INVESTIGATOR
Canadian Memorial Chiropractic College
Joy MacDermid, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Marion McGregor, DC, PhD
Role: PRINCIPAL_INVESTIGATOR
Canadian Memorial Chiropractic College
Michael Pierrynowski, PhD
Role: PRINCIPAL_INVESTIGATOR
McMaster University
Richard Ruegg, PhD, DC
Role: PRINCIPAL_INVESTIGATOR
Canadian Memorial Chiropractic College
Julita A Teodorczyk-Injeyan, PhD
Role: PRINCIPAL_INVESTIGATOR
Canadian Memorial Chiropractic College
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University
Hamilton, Ontario, Canada
Canadian Memorial Chiropractic College
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NRG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.